Last reviewed · How we verify
NCT05269511: CHM COVID-19
Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts
NA trial testing Chinese herbal medicine is in the form of granules (9 g/sachet), which is comprised of ten medicinal herbs. in Healthy Participants in 2,163 participants. Completed in 22 June 2022.
22 June 2022
Quick facts
| Lead sponsor | Hong Kong Baptist University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 2,163 |
| Start date | 14 March 2022 |
| Primary completion | 22 June 2022 |
| Estimated completion | 22 June 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Chinese herbal medicine is in the form of granules (9 g/sachet), which is comprised of ten medicinal herbs.
Conditions studied
- Healthy Participants — all drugs for Healthy Participants →
Sponsor
Hong Kong Baptist University
Who can join
16 and older, any sex, with Healthy Participants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized, blank-controlled study in adults with household contact exposure to individuals with SARS-CoV-2 infection. All subjects in the study will be household contacts with close exposure to the first household member known to be newly infected with SARS-CoV-2. Subjects in each cohort will be randomly assigned to the Chinese herbal medicine treatment group or blank control group in a 4:1 ratio, followed by 1 week of the treatment period and 2 weeks of follow-up.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy and safety of Chinese herbal medicine to prevent and treat COVID-19 household close contacts in Hong Kong: an open-label, randomized controlled trial.
Du P, Lam WC, Leung C, Li H, et al · · 2024 · cited 1× · PMID 38799438 · DOI 10.3389/fimmu.2024.1359331
Verify or expand the search:
- PubMed search for NCT05269511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Participants
Currently open trials in the same condition.
- NCT07469085 — A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Partici · Phase 1 · recruiting
- NCT07503990 — Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance · NA · recruiting
- NCT07474987 — Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury · recruiting
- NCT07511205 — A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participa · Phase 1 · recruiting
- NCT07448155 — A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous A · Phase 1 · active not recruiting
Other Hong Kong Baptist University trials
Trials by the same sponsor.
- NCT07469423 — Continuous Music and Sports Training for Children · NA · not yet recruiting
- NCT07411456 — School-based Active Play Intervention to Facilitate Movement Behaviours and Fundamental Movement Skills in Primary Schoo · NA · not yet recruiting
- NCT07243223 — Urinary Incontinence in Older Hong Kong Women: A Cross-sectional Study · not yet recruiting
- NCT07056179 — Brief Behavioral Intervention to Maintain Sleep Regularity in Young Adults Over the Christmas Break · NA · not yet recruiting
- NCT06741878 — A Biopsychosocial Approach to Improving Multidimensional Frailty Status in Community-Dwelling Older Adults · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05269511 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hong Kong Baptist University
- Last refreshed: 20 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05269511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing